SToP: Venous Thromboembolism Screening in the Trauma Population : SToP: Venous Thromboembolism Screening in the Trauma Population
This is a prospective, randomized vanguard trial of trauma patients admitted to the trauma surgery service at Intermountain Medical Center who are deemed to be at high risk for venous thromboembolism. Once identified and enrolled, subjects will be randomized to receive bilateral lower extremity duplex ultrasound surveillance versus no surveillance. The study will compare the two groups with regard to deep vein thrombosis, pulmonary embolism, and major and clinically relevant bleeding episode rates, both during the index hospitalization and at 90 days post-discharge..
| Medienart: |
|
|---|
Klinische Studie| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
ClinicalTrials.gov - (2018) vom: 29. Nov. Zur Gesamtaufnahme - year:2018 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: Link to the current ClinicalTrials.gov record., First posted: December 1, 2016, Last downloaded: ClinicalTrials.gov processed this data on June 14, 2021, Last updated: June 15, 2021 |
|---|
| Study ID: |
NCT02978950 |
|---|---|
| Veröffentlichungen zur Studie: |
|
| fisyears: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
CTG002309793 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | CTG002309793 | ||
| 003 | DE-627 | ||
| 005 | 20230425195806.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210408s2018 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)CTG002309793 | ||
| 035 | |a (UBBS_Klinische_Studien)NCT02978950 | ||
| 035 | |a (UBBS_Klinische_Studien)1050048 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a SToP: Venous Thromboembolism Screening in the Trauma Population |b SToP: Venous Thromboembolism Screening in the Trauma Population |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: Link to the current ClinicalTrials.gov record., First posted: December 1, 2016, Last downloaded: ClinicalTrials.gov processed this data on June 14, 2021, Last updated: June 15, 2021 | ||
| 520 | |a This is a prospective, randomized vanguard trial of trauma patients admitted to the trauma surgery service at Intermountain Medical Center who are deemed to be at high risk for venous thromboembolism. Once identified and enrolled, subjects will be randomized to receive bilateral lower extremity duplex ultrasound surveillance versus no surveillance. The study will compare the two groups with regard to deep vein thrombosis, pulmonary embolism, and major and clinically relevant bleeding episode rates, both during the index hospitalization and at 90 days post-discharge. | ||
| 650 | 2 | |a Thrombosis | |
| 650 | 2 | |a Thromboembolism | |
| 650 | 2 | |a Venous Thromboembolism | |
| 650 | 2 | |a Venous Thrombosis | |
| 650 | 2 | |a Wounds and Injuries | |
| 650 | 2 | |a Multiple Trauma | |
| 650 | 4 | |a Medical Condition: Venous Thromboembolism, Deep Vein Thrombosis, Trauma, Multiple | |
| 650 | 4 | |a Study Type: Interventional | |
| 650 | 4 | |a Recruitment Status: Unknown status | |
| 650 | 4 | |a 610 | |
| 773 | 0 | 8 | |i Enthalten in |t ClinicalTrials.gov |g (2018) vom: 29. Nov. |
| 773 | 1 | 8 | |g year:2018 |g day:29 |g month:11 |
| 856 | 4 | 0 | |u https://clinicaltrials.gov/show/NCT02978950 |z kostenfrei |3 Volltext |
| 912 | |a GBV_CTG | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2018 |b 29 |c 11 | ||